Latest Trustworthy News from Dr. Mercola - delivered straight to your inbox!
preorder cellular health book preorder cellular health book

GSK and Sanofi COVID-19 Vaccine Produced in Insect Cells With Squalene Adjuvant

  • May 05, 2020

Two of the world’s largest vaccine manufacturers are using DNA technology, insect cells and a squalene adjuvant, AS03, as the basis to develop a COVID-19 vaccine together. GlaxoSmithKline (GSK) and Sanofi Pasteur are partners in the enterprise, with clinical trials set to begin in 2020. The squalene adjuvant is aluminum-based and is designed to induce a higher immune response through an enhanced inflammatory process. While aluminum is currently in other vaccines such as hepatitis...